| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A phase 1b study of AFM13 in combination with pembrolizumab in patients with relapsed or refractory Hodgkin lymphoma
|
Bartlett, Nancy L.
|
|
|
136 |
21 |
p. 2401-2409
|
artikel
|
| 2 |
Architecture and interior design of Hodgkin lymphoma
|
Steidl, C.
|
|
|
136 |
21 |
p. 2367-2369
|
artikel
|
| 3 |
A simple Rx for congenital erythropoietic porphyria
|
Abkowitz, Janis L.
|
|
|
136 |
21 |
p. 2371-2372
|
artikel
|
| 4 |
BETting on stem cell expansion
|
Staal, Frank J.T.
|
|
|
136 |
21 |
p. 2364-2365
|
artikel
|
| 5 |
CANOMAD: a neurological monoclonal gammopathy of clinical significance that benefits from B-cell–targeted therapies
|
Le Cann, Marie
|
|
|
136 |
21 |
p. 2428-2436
|
artikel
|
| 6 |
CANOMAD syndrome
|
|
|
|
136 |
21 |
p. 2481
|
artikel
|
| 7 |
CD38 deletion of human primary NK cells eliminates daratumumab-induced fratricide and boosts their effector activity
|
Naeimi Kararoudi, Meisam
|
|
|
136 |
21 |
p. 2416-2427
|
artikel
|
| 8 |
Chagas disease initially diagnosed in a lymph node
|
Verma, Anuj
|
|
|
136 |
21 |
p. 2478
|
artikel
|
| 9 |
Editorial Board
|
|
|
|
136 |
21 |
p. i
|
artikel
|
| 10 |
Fetal hemoglobin in sickle cell anemia
|
Steinberg, Martin H.
|
|
|
136 |
21 |
p. 2392-2400
|
artikel
|
| 11 |
Gill JC, Castaman G, Windyga J, et al. Hemostatic efficacy, safety, and pharmacokinetics of a recombinant von Willebrand factor in severe von Willebrand disease. Blood. 2015;126(17):2038-2046.
|
|
|
|
136 |
21 |
p. 2479-2480
|
artikel
|
| 12 |
Harnessing lymphoma epigenetics to improve therapies
|
Yang, Haopeng
|
|
|
136 |
21 |
p. 2386-2391
|
artikel
|
| 13 |
Hodgkin lymphoma: outsmarting HRS cells
|
Connors, Joseph M.
|
|
|
136 |
21 |
p. 2362-2364
|
artikel
|
| 14 |
Iron chelation rescues hemolytic anemia and skin photosensitivity in congenital erythropoietic porphyria
|
Blouin, Jean-Marc
|
|
|
136 |
21 |
p. 2457-2468
|
artikel
|
| 15 |
MLL-menin and FLT3 inhibitors team up for AML
|
Perl, Alexander E.
|
|
|
136 |
21 |
p. 2369-2370
|
artikel
|
| 16 |
Monoclonal IgM and neuropathy: not always anti-MAG
|
Jaccard, Arnaud
|
|
|
136 |
21 |
p. 2366-2367
|
artikel
|
| 17 |
Patients with refractory catastrophic antiphospholipid syndrome respond inconsistently to eculizumab
|
Yelnik, Cécile M.
|
|
|
136 |
21 |
p. 2473-2477
|
artikel
|
| 18 |
Procoagulant activities of skeletal and cardiac muscle myosin depend on contaminating phospholipid
|
Novakovic, Valerie A.
|
|
|
136 |
21 |
p. 2469-2472
|
artikel
|
| 19 |
Rosetting T cells in Hodgkin lymphoma are activated by immunological synapse components HLA class II and CD58
|
Veldman, Johanna
|
|
|
136 |
21 |
p. 2437-2441
|
artikel
|
| 20 |
RUNX1 and CBFβ-SMMHC transactivate target genes together in abnormal myeloid progenitors for leukemia development
|
Zhen, Tao
|
|
|
136 |
21 |
p. 2373-2385
|
artikel
|
| 21 |
RUNX1 and inv(16) are frenemies in AML
|
Rao, Sridhar
|
|
|
136 |
21 |
p. 2361-2362
|
artikel
|
| 22 |
Synergistic targeting of FLT3 mutations in AML via combined menin-MLL and FLT3 inhibition
|
Dzama, Margarita M.
|
|
|
136 |
21 |
p. 2442-2456
|
artikel
|
| 23 |
The BET inhibitor CPI203 promotes ex vivo expansion of cord blood long-term repopulating HSCs and megakaryocytes
|
Hua, Peng
|
|
|
136 |
21 |
p. 2410-2415
|
artikel
|
Tijdschrift beschrijving